The Metabolites and Mechanism Analysis of Genistin against Hyperlipidemia via the UHPLC-Q-Exactive Orbitrap Mass Spectrometer and Metabolomics
Molecules · 2023
DOI: 10.3390/molecules28052242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Zhe Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Binzhou Medical University, Yantai 264003, China. Hauptthemen laut MEDLINE: Hyperlipidemias, Isoflavones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jia Yu Zhang, the Taishan Young Scholar Program of Shandong, General Program of National Natural Science Foundation of China.
Abstract (Originalsprache)
Genistin, an isoflavone, has been reported to have multiple activities. However, its improvement of hyperlipidemia is still unclear, and the same is true with regard to its mechanism. In this study, a high-fat diet (HFD) was used to induce a hyperlipidemic rat model. The metabolites of genistin in normal and hyperlipidemic rats were first identified to cause metabolic differences with Ultra-High-Performance Liquid Chromatography Quadrupole Exactive Orbitrap Mass Spectrometry (UHPLC-Q-Exactive Orbitrap MS). The relevant factors were determined via ELISA, and the pathological changes of liver tissue were examined via H&E staining and Oil red O staining, which evaluated the functions of genistin. The related mechanism was elucidated through metabolomics and Spearman correlation analysis. The results showed that 13 metabolites of genistin were identified in plasma from normal and hyperlipidemic rats. Of those metabolites, seven were found in normal rat, and three existed in two models, with those metabolites being involved in the reactions of decarbonylation, arabinosylation, hydroxylation, and methylation. Three metabolites, including the product of dehydroxymethylation, decarbonylation, and carbonyl hydrogenation, were identified in hyperlipidemic rats for the first time. Accordingly, the pharmacodynamic results first revealed that genistin could significantly reduce the level of lipid factors (p < 0.05), inhibited lipid accumulation in the liver, and reversed the liver function abnormalities caused by lipid peroxidation. For metabolomics results, HFD could significantly alter the levels of 15 endogenous metabolites, and genistin could reverse them. Creatine might be a beneficial biomarker for the activity of genistin against hyperlipidemia, as revealed via multivariate correlation analysis. These results, which have not been reported in the previous literature, may provide the foundation for genistin as a new lipid-lowering agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Binzhou Medical University, Yantai 264003, China.
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250300, China.
Förderung
- Jia Yu Zhang
- the Taishan Young Scholar Program of Shandong
- General Program of National Natural Science Foundation of China
- the Shandong Province Chinese Herbal Medicine and Decoction Piece Standard Research Topic
- the Yantai Campus Integration Development Project
- the Binzhou Medical University Scientific Research Fund for High-level Talents
- the Young and Creative Team for Talent Introduction of Shandong Provinc
- the Project of Shandong Provincial Natural Fund
Zitieren
APA
Li, Z., Dong, W., Li, Y., Liu, X., Wang, H., Dai, L., Zhang, J., & Wang, S. (2023). The Metabolites and Mechanism Analysis of Genistin against Hyperlipidemia via the UHPLC-Q-Exactive Orbitrap Mass Spectrometer and Metabolomics. Molecules. https://doi.org/10.3390/molecules28052242
Vancouver
Li Z, Dong W, Li Y, Liu X, Wang H, Dai L, et al. The Metabolites and Mechanism Analysis of Genistin against Hyperlipidemia via the UHPLC-Q-Exactive Orbitrap Mass Spectrometer and Metabolomics. Molecules. 2023. doi:10.3390/molecules28052242
BibTeX
@article{Li2023,
author = {Li, Zhe and Dong, Weichao and Li, Yanan and Liu, Xin and Wang, Hong and Dai, Long and Zhang, Jiayu and Wang, Shaoping},
title = {The Metabolites and Mechanism Analysis of Genistin against Hyperlipidemia via the UHPLC-Q-Exactive Orbitrap Mass Spectrometer and Metabolomics},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28052242}
}
EUVIMED